The analysis of pathological change in liver after eradication of Hepatitis C virus.

The analysis of pathological change in liver after eradication of Hepatitis C virus. - The analysis of pathological change in liver after eradication of Hepatitis C virus.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037194

Enrollment

Registered

2019-06-27

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients who obtained SVR by DAA therapy. the patients who under who underwent CT imaging at pretreatment, SVR, and 48 weeks after SVR.

Exclusion criteria

Exclusion criteria: the patients with any other liver diseases, including autoimmune hepatitis, drug-induced liver disease, and primary biliary cholangitis. Patients with Child-Pugh class B and C cirrhosis or who developed hepatocellular carcinoma during this study period were excluded.

Design outcomes

Primary

Measure	Time frame
the liver function and pathological status after eradication of HCV.	—

Countries

Japan

Contacts

Public Contactseko yuya

Kyoto Prefectural University of Medicine Department of Molecular Gastroenterology and Hepatology

yuyaseko@koto.kpu-m.ac.jp0752515519

Outcome results